Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


XOMA appoints Paul Rubin vice-president and CMO

This article was originally published in Scrip

Executive Summary

XOMA, a company focused on the discovery and development of novel antibody therapeutics, has appointed Dr Paul Rubin vice-president and chief medical officer. Dr Rubin was previously CMO at Funxional Therapeutics. He will succeed Dr Patrick Scannon, who has been executive vice-president and CMO since 2009 and will now serve as executive vice-president and chief scientific officer.

Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts